T. Kawano

发表

Telomerase activation as a repair response to radiation-induced DNA damage in Y79 retinoblastoma cells.

Hisashi Yamada, M. Akiyama, O. Yamada, 2013, Cancer letters.

MUC1 oncoprotein blocks death receptor-mediated apoptosis by inhibiting recruitment of caspase-8.

D. Kufe, S. Kharbanda, D. Raina, 2008, Cancer research.

Histone deacetylase inhibitors valproic acid and depsipeptide sensitize retinoblastoma cells to radiotherapy by increasing H2AX phosphorylation and p53 acetylation-phosphorylation.

S. Iwase, Hisashi Yamada, M. Akiyama, 2010, International journal of oncology.

MUC1 oncoprotein regulates Bcr-Abl stability and pathogenesis in chronic myelogenous leukemia cells.

D. Kufe, R. Stone, D. Raina, 2007, Cancer research.

MUC 1 Oncoprotein Regulates Bcr-Abl Stability and Pathogenesis in Chronic Myelogenous Leukemia Cells

D. Kufe, R. Stone, D. Raina, 2007 .

Relation between outcomes and localisation of p-mTOR expression in gastric cancer

K. Kojima, J. Kumagai, K. Sugihara, 2009, British Journal of Cancer.

Inactivation of ERK accelerates erythroid differentiation of K562 cells induced by herbimycin A and STI571 while activation of MEK1 interferes with it

Y. Furukawa, S. Iwase, Hisashi Yamada, 2004, Molecular and Cellular Biochemistry.

MUC1 induces metastasis in esophageal squamous cell carcinoma by upregulating matrix metalloproteinase 13

Zhugang Wang, Jie Yang, T. Kawano, 2011, Laboratory Investigation.

Phase I/II study of S-1 combined with irinotecan for metastatic advanced gastric cancer

K. Kojima, W. Ichikawa, Z. Nihei, 2006, British Journal of Cancer.

No VH Somatic Hypermutation Was Detected in B-Cells of a Patient with Macroglobulinemia Due to Splenic Marginal Zone Lymphoma

S. Iwase, Hisashi Yamada, Masayuki Kobayashi, 2002, International journal of hematology.

Depsipeptide enhances imatinib mesylate-induced apoptosis of Bcr-Abl-positive cells and ectopic expression of cyclin D1, c-Myc or active MEK abrogates this effect.

Y. Furukawa, S. Iwase, Hisashi Yamada, 2004, Anticancer research.

Terminal differentiation of chronic myelogenous leukemia cells is induced by targeting of the MUC1-C oncoprotein

L. Yin, D. Kufe, R. Stone, 2010, Cancer biology & therapy.

Antitumor activity of TMPyP4 interacting G-quadruplex in retinoblastoma cell lines.

Y. Yuza, Hisashi Yamada, M. Akiyama, 2009, Experimental eye research.

MUC1 oncoprotein promotes growth and survival of human multiple myeloma cells.

D. Kufe, R. Ahmad, T. Kawano, 2008, International journal of oncology.

MUC 1 oncoprotein promotes growth and survival of human multiple myeloma cells

R. Ahmad, T. Kawano, H. Nogi, 2022 .

Ganglioside as an endogenous growth suppressor for glomerular mesangial cells.

N. Tsuboi, T. Ohno, T. Hosoya, 2001, Kidney international.

A novel isocoumarin derivative induces mitotic phase arrest and apoptosis of human multiple myeloma cells

D. Kufe, S. Kharbanda, D. Avigan, 2006, Cancer Chemotherapy and Pharmacology.

Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells.

L. Yin, D. Kufe, S. Kharbanda, 2009, Cancer research.

MUC1-C Oncoprotein Promotes STAT3 Activation in an Autoinductive Regulatory Loop

D. Kufe, S. Kharbanda, R. Ahmad, 2011, Science Signaling.

The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop.

D. Kufe, S. Kharbanda, S. Duraisamy, 2007, Molecular cell.

Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors.

H. Mizoguchi, Hisashi Yamada, M. Akiyama, 2002, Cancer letters.

Biological effects of a relatively low concentration of 1-b-D-arabinofuranosylcytosine in K562 cells: Alterations of the cell cycle, erythroid-differentiation, and apoptosis

S. Iwase, Hisashi Yamada, M. Nagai, 1998, Molecular and Cellular Biochemistry.

MUC1-C oncoprotein functions as a direct activator of the nuclear factor-kappaB p65 transcription factor.

D. Kufe, S. Kharbanda, D. Raina, 2009, Cancer research.

A novel variant of acute myelomonocytic leukemia carrying t(3;12)(q26;p13) with characteristics of 3q21q26 syndrome.

H. Yamada, Y. Furukawa, J. Kikuchi, 1998, International journal of hematology.

Pretreatment with interferon-alpha radiosensitizes Daudi cells modulating gene expression and biomarkers.

S. Iwase, Hisashi Yamada, T. Kawano, 2005, Anticancer research.

Ectopic cyclin D1 expression blocks STI571-induced erythroid differentiation of K562 cells.

Y. Furukawa, S. Iwase, Hisashi Yamada, 2004, Leukemia research.

Histone deacetylase inhibitors valproic acid and depsipeptide sensitize retinoblastoma cells to radiotherapy by increasing H2AX phosphorylation and p53 acetylation-phosphorylation.

Masaharu Akiyama, Hisashi Yamada, Takaaki Yanagisawa, 2010, International journal of oncology.

MUC1 oncoprotein blocks death receptor-mediated apoptosis by inhibiting recruitment of caspase-8.

D. Kufe, S. Kharbanda, D. Raina, 2008, Cancer research.

Phosphoglycerate kinase deficiency due to a novel mutation (c. 1180A>G) manifesting as chronic hemolytic anemia in a Japanese boy

Hisashi Yamada, M. Akiyama, H. Ida, 2014, International Journal of Hematology.